Wednesday, 10 October 2018

FDA staff says AcelRx opioid painkiller is not better than rivals

AcelRx Pharmaceuticals Inc's opioid painkiller offers no apparent advantage to currently available therapies, staff reviewers of the U.S. Food and Administration said on Wednesday.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)